Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(4 sites)
United States
Orange County Research Center, Lake Forest, California Panax Clinical Research, Miami Lakes, Florida Orlando Clinical Research Center, Orlando, Florida Alliance for Multispecialty Research, Knoxville, Tennessee